Gelesis Holdings, Inc. (GLS)

GLS was delisted on the 10th of April, 2023.

• Market cap: $11.6M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.

Employees: 93